Back to Newsroom

Exosome Diagnostics Raises $27 Million in Series B Financing

New York City — March 11, 2014 — Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company’s proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.